Massive study launches to map the journey of a scarring lung disease
NCT ID NCT07178392
Summary
This study aims to better understand Idiopathic Pulmonary Fibrosis (IPF) by observing over 2800 patients in China. It will collect detailed information on how the disease progresses, what symptoms patients experience, and how it affects their quality of life. The goal is to create a clearer picture of the disease to help guide future care, but it does not test any new treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, 450000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.